Stacey L. Wilda, O.d., P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 415 N 7th St, Perry, OK 73077 Phone: 580-336-0777 Fax: 580-336-0888 |
Dr. Curtis Scott Cowell, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 720 Delaware St, Perry, OK 73077 Phone: 580-336-2020 Fax: 580-336-2333 |
C Scott Cowell Od Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 720 Delaware St, Perry, OK 73077 Phone: 580-336-2020 Fax: 580-336-2333 |
Dr. Stacey Wilda, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 415 N 7th St, Perry, OK 73077 Phone: 580-336-0777 Fax: 580-336-0888 |
News Archive
Millions of people today take statins to help lower their cholesterol level. Currently statins are prescribed to patients based on their future risk of cardiovascular disease - mainly driven by age - which excludes many individuals who may benefit from them. A new study led by the Research Institute of the McGill University Health Centre in Montreal, with collaborators from the United-States, is changing the way we think about prescribing statins. The research team has developed a new approach to determine which individuals should receive these important medications.
Children are likely to have stronger muscles if their mothers had a higher level of vitamin D in their body during pregnancy, according to new research from the Medical Research Council Lifecourse Epidemiology Unit (MRC LEU) at the University of Southampton.
Prematics, a leading provider of e-prescribing and care communication solutions, today announced a partnership with NaviNet, America's largest real-time healthcare communications network, to enable the delivery of healthcare content and applications to mobile devices.
CEVEC Pharmaceuticals, the German developer of a novel human expression system derived from amniocytes, announced today the signing of an exclusive license option agreement with Pevion Biotech, the Swiss vaccine company. The agreement enables Pevion Biotech to exclusively use CEVEC's transient CAP-Tâ„¢ cell expression technology to manufacture and commercialize a protein antigen for vaccination against a widespread human infectious disease.
› Verified 8 days ago